Inspire Medical Systems (INSP) Free Cash Flow (QoQ) (2017 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Inspire Medical Systems | 1.17 Bn | 889.44 Mn | 176.91 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -94.10% |
| Dec 31, 2025 | -23.34% |
| Sep 30, 2025 | 41,256.89% |
| Jun 30, 2025 | 101.67% |
| Mar 31, 2025 | -114.40% |
| Dec 31, 2024 | 31.42% |
| Sep 30, 2024 | 3,385.12% |
| Jun 30, 2024 | -55.56% |
| Mar 31, 2024 | -63.16% |
| Dec 31, 2023 | 375.64% |
| Sep 30, 2023 | -1,513.50% |
| Jun 30, 2023 | 104.65% |
| Mar 31, 2023 | -121.83% |
| Dec 31, 2022 | 284.77% |
| Sep 30, 2022 | 201.97% |
| Jun 30, 2022 | 57.38% |
| Mar 31, 2022 | -403.87% |
| Dec 31, 2021 | 408.60% |
| Sep 30, 2021 | 87.36% |
| Jun 30, 2021 | -0.47% |
| Mar 31, 2021 | -148.66% |
| Dec 31, 2020 | 53.44% |
| Sep 30, 2020 | 60.50% |
| Jun 30, 2020 | -70.54% |
| Mar 31, 2020 | -297.72% |
| Dec 31, 2019 | 5.71% |
| Sep 30, 2019 | 71.04% |
| Jun 30, 2019 | -23.40% |
| Mar 31, 2019 | -303.49% |
| Dec 31, 2018 | 21.76% |
| Sep 30, 2018 | 42.56% |
| Jun 30, 2018 | 3.72% |
| Mar 31, 2018 | -92.42% |
| Dec 31, 2017 | -2.71% |
| Sep 30, 2017 | 19.67% |
| Jun 30, 2017 | 27.29% |